It is well known that the regulation of choline acetyltransferase (ChA
T) activity under physiological and pathological conditions is importa
nt for the development and neuronal activities of cholinergic systems
involved in many fundamental brain functions. This review focuses on r
ecent progress in understanding the regulation of ChAT at the levels o
f both the protein and the mRNA. A deficiency in ChAT activity has bee
n reported for neurodegenerative conditions such as Alzheimer's diseas
e, amyotrophic lateral sclerosis, and schizophrenia. Although a major
feature of ChAT regulation is likely to involve the spatial and tempor
al control of transcription, regulation of expression can also be at t
he level of RNA processing, transport/translocation, turnover, or tran
slation. In addition, there is increasing evidence that ChAT might be
regulated at the posttranslational level by compartmentation and/or co
valent modification, i.e., phosphorylation, as well as noncovalent mod
ification (protein-protein interaction, etc.). Synaptic activity and t
he state of neuronal transmission may also involve the regulation of C
hAT at different levels via both positive and negative feedback loops,
as was demonstrated in the characterization of two ChAT mutant Drosop
hila strains. Clearly, identification of cholinergic-specific elements
and the characterization of the trans-acting factors that bind to the
m represent an important area of future research. Equally important is
research on the mechanisms governing ChAT as an enzymatic entity. The
future should be an exciting time during which we look forward to the
elucidation of the cholinergic signal and its regulation as well as t
he determination of the three-dimensional structure of the enzyme.